Detalhe da pesquisa
1.
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.
Cancer
; 128(13): 2441-2448, 2022 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35417564